Abstracts (HTML) Autorenliste

Adamovic, I.

Drug interactions in patients undergoing opioid maintenance therapy
Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism

Antony, G.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Bach, P.

Therapeutic drug monitoring in relapse prevention of alcohol dependent patients

Banaschewski, T.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Bergemann, N

Mood stabilizers during pregnancy – significance of therapeutic drug monitoring

Bergemann, N.

The therapeutic reference range for olanzapine revised – how to combine old and new findings

Binder, L.

Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism

Bleich, S.

Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting

Boettcher, M

Drug interactions in patients undergoing opioid maintenance therapy

Böttcher, K.

Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination

Böttcher, M.

Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression

Briegel, W.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Clement, H.W.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis

Conca, A.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Correll, C.U.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Deckert, J.

Antidepressants in pregnancy – focus on therapeutic drug monitoring

Degner, D.

Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism

de Kroon, M.M.J.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

de Winter, B.C.M.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Dierckx, B.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Egberts, K.

Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring

Egberts, K.M.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Eichentopf, L.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Eichhorn, A.C.

Discussion: Genotyping in real life setting

Elsner, B

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Engelmann, J.

Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Faltraco, F.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis

Fekete, S.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring

Fiedler, K.

Antidepressants in pregnancy – focus on therapeutic drug monitoring

Fleischhaker, C.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Florio, V.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Funk, CSM

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Gehrmann, A.

Antidepressants in pregnancy – focus on therapeutic drug monitoring

Geissler, J.

Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring

Gerlach, M.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Gilles, M.

Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression

Grohmann, R.

Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting

Gründer, G

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Gründer, G.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
How valid are therapeutic reference ranges for psychotropic drugs?
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Grüner, J.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis

Güntzel, T.

Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring

Hart, M X

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Hart, X. M.

Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Hart, X.M.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
How valid are therapeutic reference ranges for psychotropic drugs?
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination

Havemann-Reinecke, U.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Drug interactions in patients undergoing opioid maintenance therapy
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Hefner, G.

Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Hellenschmidt, T.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Hermans, R.A.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Heuschmann, P.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Hiemke, C

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors
Drug interactions in patients undergoing opioid maintenance therapy

Hiemke, C.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
How valid are therapeutic reference ranges for psychotropic drugs?
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Hillegers, M.H.J.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Hirjak, D.

Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination

Imgart, H.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Kaess, M.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Karwautz, A.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Kiefer, F.

Therapeutic drug monitoring in relapse prevention of alcohol dependent patients

Kittel-Schneider, S.

Antidepressants in pregnancy – focus on therapeutic drug monitoring

Kloosterboer, S.M.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Koch, B.C.P.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Kölch, M.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Kouijzer, M.E.J.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Kreutz, R

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Kuzin, M.

Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Lense, X.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis

Lense, X.M.

Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
The therapeutic reference range for olanzapine revised – how to combine old and new findings

Leutritz, A.L.

Antidepressants in pregnancy – focus on therapeutic drug monitoring

Lieb, K.

Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Malzahn, U.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Menke, A.

Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?

Michaelis, S.

Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism

Molden, E.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Using TDM data to study treatment failure

Mössner, R.

Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?

Nasserinejad, K.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Neubert, A.

Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring

Paulzen, M.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis

Plener, P.L.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Preis, K.

Antidepressants in pregnancy – focus on therapeutic drug monitoring

Reichart, C.G.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Reinwald, J.

Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression

Reis, M.

A compilation of serum concentrations of 12 antipsychotic drugs in a therapeutic drug monitoring setting
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Reitzle, K.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Renner, T.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Reuter-Dang, S.Y.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Rexroth, C.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Rieken, R.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Riemer, G T

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Riemer, T.G.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Rock, H.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Romanos, M.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring

Sartorius, A.

Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression

Sassen, S.D.T.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Scherf-Clavel, M.

Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
Antidepressants in pregnancy – focus on therapeutic drug monitoring
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Schneider, H.

Influences on therapeutic drug monitoring of psychotropic drugs – analyst's perspective

Schoretsanitis, G.

Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis
Is it Time to Reevaluate the Therapeutic Reference Range for the Antidepressant Drug Venlafaxine?
The relevance of TDM for long-acting injectable antipsychotics
The therapeutic reference range for olanzapine revised – how to combine old and new findings
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Schulte-Körne, G.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Seretti, A.

Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

Shipkova, M.

Liquid Chromatography/Tandem Mass Spectrometry (LC-MSMS) Analysis of neuropsychiatric drugs: Challenges from the perspective of the laboratory physician

Smigielski, L.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Spangemacher, M.

Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination

Streit, F.

Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism

Taurines, R.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring

Theisen, F.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Tini, E.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Toto, S.

Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting

Uhr, M.

The therapeutic reference range for olanzapine revised – how to combine old and new findings

Unterecker, S.

Antidepressants in pregnancy – focus on therapeutic drug monitoring
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

van Braam, L.

Antidepressants in pregnancy – focus on therapeutic drug monitoring

van Daalen, E.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

van Schaik, R.H.N.

Linking pharmacokinetics of aripiprazole to side effects and effectiveness in children and adolescents

Vierke, C

Drug interactions in patients undergoing opioid maintenance therapy

Walitza, S.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Walter, M.

Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression

Wendler, N.

Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination

Wesner, K.

The therapeutic reference range for olanzapine revised – how to combine old and new findings

Wewetzer, C.

Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Therapeutic drug monitoring of mirtazapine in children and adolescents: Analysis of dose, steady-state concentration and responsiveness in a naturalistic clinical setting

Zernig, G.

The therapeutic reference range for olanzapine revised – how to combine old and new findings
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range